%0 Case Reports
%T Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone.
%A Laird J
%A Falk RH
%A Coyle M
%A Cuddy SAM
%J JACC Case Rep
%V 2
%N 15
%D Dec 2020
%M 34317174
暂无%R 10.1016/j.jaccas.2020.09.037
%X An 85-year-old women with transthyretin cardiac amyloidosis presented with generalized weakness, elevated liver function test levels, and creatinine kinase consistent with rhabdomyolysis 1 week after starting tafamidis. She was already taking atorvastatin and amiodarone, raising the possibility of a drug-drug interaction inhibiting the breakdown and excretion of atorvastatin, causing drug-induced rhabdomyolysis. (Level of Difficulty: Intermediate.).